Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
about
Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis modelLarge-scale synthesis and functional elements for the antimicrobial activity of defensinsEvidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasoneTargeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsTherapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides.Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Role of the LytSR two-component regulatory system in adaptation to cationic antimicrobial peptides in Staphylococcus aureusRegulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strainsTricarboxylic acid cycle-dependent attenuation of Staphylococcus aureus in vivo virulence by selective inhibition of amino acid transport.Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.Amikacin: Uses, Resistance, and Prospects for Inhibition.
P2860
Q24558684-6790F913-3333-46D9-B4BA-4741854A4D6EQ28344129-7E5EDC02-6503-4BBD-86EA-94DF5C7BB4D3Q28364129-9D3B95A0-C07F-491C-884B-E28F6CBF8350Q28486717-46B92D6F-8197-4F38-9266-E4001CD720DAQ33981379-B7E22BBD-D2F3-4841-AFDD-05A99F4009B3Q34045273-3BC8A6A6-C52A-4D16-AAD9-018B48F02B29Q34595733-FBFE8567-07F3-430B-B8F2-B37CA1999012Q36364106-7D8EC97C-5882-4CD7-81B9-77007D436D9BQ36396117-E2B9088A-84A5-4411-B5F3-2DC4E5BEC46EQ37036548-658BEBBA-3424-4603-89A6-6FAAC081BE40Q37204125-AE6A4D2F-6519-408F-87AC-54756A3E3CC6Q37355921-BD3A472B-F957-4E02-8574-2132DF279B30Q42082902-A45EF347-A8A5-4E7A-9EC9-580DE42A3224Q52744431-F3CEE686-95EF-40A9-8247-699EC597283C
P2860
Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@ast
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@en
type
label
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@ast
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@en
prefLabel
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@ast
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@en
P2093
P2860
P1476
Comparative efficacies of lipo ...... nd echocardiographic analyses.
@en
P2093
L I Kupferwasser
P2860
P304
P407
P577
1999-07-01T00:00:00Z